170 related articles for article (PubMed ID: 9846373)
1. [Significance of ras mutations in pancreatic diseases].
Löhr M; Liebe S; Lowenfels AB
Z Gastroenterol; 1998 Oct; 36(10):929-32. PubMed ID: 9846373
[No Abstract] [Full Text] [Related]
2. The K-ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epithelium.
Lüttges J; Schlehe B; Menke MA; Vogel I; Henne-Bruns D; Klöppel G
Cancer; 1999 Apr; 85(8):1703-10. PubMed ID: 10223563
[TBL] [Abstract][Full Text] [Related]
3. [Mutations of the Ki-ras gene: an early event in pancreatic carcinogenesis].
Knoll MR; Singer MV
Z Gastroenterol; 1994 Jul; 32(7):420-1. PubMed ID: 7975782
[No Abstract] [Full Text] [Related]
4. NFATc1 Links EGFR Signaling to Induction of Sox9 Transcription and Acinar-Ductal Transdifferentiation in the Pancreas.
Chen NM; Singh G; Koenig A; Liou GY; Storz P; Zhang JS; Regul L; Nagarajan S; Kühnemuth B; Johnsen SA; Hebrok M; Siveke J; Billadeau DD; Ellenrieder V; Hessmann E
Gastroenterology; 2015 May; 148(5):1024-1034.e9. PubMed ID: 25623042
[TBL] [Abstract][Full Text] [Related]
5. [Pathogenesis of pancreatic carcinoma].
Schmid RM
Z Gastroenterol; 2002 Dec; 40 Suppl 2():58-61. PubMed ID: 12467012
[No Abstract] [Full Text] [Related]
6. Analysis of K-ras mutations in pancreatic tissue after fine needle aspirates.
Pabst B; Arps S; Binmoeller K; Thul R; Walsemann G; Fenner C; Klapdor R
Anticancer Res; 1999; 19(4A):2481-3. PubMed ID: 10470178
[TBL] [Abstract][Full Text] [Related]
7. [Detection of mutated ras-oncogene in pancreatic cancers: improved diagnostic possibilities using molecular biology techniques?].
Herzig KH; Schäffer M; Rosewicz S; Fölsch UR
Z Gastroenterol; 1992 Jun; 30(6):436-9. PubMed ID: 1636278
[TBL] [Abstract][Full Text] [Related]
8. Relationship between K-ras mutation and the expression of p21WAF1/CIP1 and p53 in chronic pancreatitis and pancreatic adenocarcinoma.
Hermanová M; Lukás Z; Kroupová I; Kleibl Z; Novotný J; Nenutil R; Pazourková M; Brázdil J; Kren L; Díte P
Neoplasma; 2003; 50(5):319-25. PubMed ID: 14628083
[TBL] [Abstract][Full Text] [Related]
9. Neoplasms of the ampulla of vater with concurrent pancreatic intraductal neoplasia: a histological and molecular study.
Agoff SN; Crispin DA; Bronner MP; Dail DH; Hawes SE; Haggitt RC
Mod Pathol; 2001 Mar; 14(3):139-46. PubMed ID: 11266517
[TBL] [Abstract][Full Text] [Related]
10. Preinvasive pancreatic neoplasia of ductal phenotype induced by acinar cell targeting of mutant Kras in transgenic mice.
Grippo PJ; Nowlin PS; Demeure MJ; Longnecker DS; Sandgren EP
Cancer Res; 2003 May; 63(9):2016-9. PubMed ID: 12727811
[TBL] [Abstract][Full Text] [Related]
11. Detection of K-ras point mutation at codon 12 in pancreatic diseases: a study in a Brazilian casuistic.
Kubrusly MS; Cunha JE; Bacchella T; Abdo EE; Jukemura J; Penteado S; Morioka CY; de Souza LJ; Machado MC
JOP; 2002 Sep; 3(5):144-51. PubMed ID: 12221329
[TBL] [Abstract][Full Text] [Related]
12. [Morphologic, morphometric and immunohistochemical studies on pancreatic intraductal hyperplasia and infiltrating carcinoma].
Tomaszewska R
Folia Med Cracov; 1999; 40(1-2):101-41. PubMed ID: 10909469
[TBL] [Abstract][Full Text] [Related]
13. The mutant K-ras oncogene causes pancreatic periductal lymphocytic infiltration and gastric mucous neck cell hyperplasia in transgenic mice.
Brembeck FH; Schreiber FS; Deramaudt TB; Craig L; Rhoades B; Swain G; Grippo P; Stoffers DA; Silberg DG; Rustgi AK
Cancer Res; 2003 May; 63(9):2005-9. PubMed ID: 12727809
[TBL] [Abstract][Full Text] [Related]
14. Predictive factors for pancreatic cancer in patients with chronic pancreatitis in association with K-ras gene mutation.
Arvanitakis M; Van Laethem JL; Parma J; De Maertelaer V; Delhaye M; Devière J
Endoscopy; 2004 Jun; 36(6):535-42. PubMed ID: 15202051
[TBL] [Abstract][Full Text] [Related]
15. Induction of Pancreatic Inflammation Accelerates Pancreatic Tumorigenesis in Mice.
Zhuang L; Zhan X; Bi Y; Ji B
Methods Mol Biol; 2019; 1882():287-297. PubMed ID: 30378063
[TBL] [Abstract][Full Text] [Related]
16. Common occurrence of multiple K-RAS mutations in pancreatic cancers with associated precursor lesions and in biliary cancers.
Laghi L; Orbetegli O; Bianchi P; Zerbi A; Di Carlo V; Boland CR; Malesci A
Oncogene; 2002 Jun; 21(27):4301-6. PubMed ID: 12082617
[TBL] [Abstract][Full Text] [Related]
17. [Pancreatic carcinoma in chronic pancreatitis with inflammatory tumor of the head of the pancreas].
Schlosser W; Schoenberg MH; Rhein E; Siech M; Gansauge F; Beger HG
Z Gastroenterol; 1996 Jan; 34(1):3-8. PubMed ID: 8776168
[TBL] [Abstract][Full Text] [Related]
18. Frequent c-Ki-ras oncogene activation in mucous cell hyperplasias of pancreas suffering from chronic inflammation.
Yanagisawa A; Ohtake K; Ohashi K; Hori M; Kitagawa T; Sugano H; Kato Y
Cancer Res; 1993 Mar; 53(5):953-6. PubMed ID: 8439969
[TBL] [Abstract][Full Text] [Related]
19. The role of Ras mutation in pancreatic cancer, precancerous lesions, and chronic pancreatitis.
Tabata T; Fujimori T; Maeda S; Yamamoto M; Saitoh Y
Int J Pancreatol; 1993 Dec; 14(3):237-44. PubMed ID: 8113625
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up of chronic pancreatitis patients with K-ras mutation in the pancreatic juice.
Kamisawa T; Takuma K; Tabata T; Egawa N; Yamaguchi T
Hepatogastroenterology; 2011; 58(105):174-6. PubMed ID: 21510309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
